latest news releases from the newsroom
Law Offices Bernard M. Gross, P.C.
Law Offices Bernard M. Gross, P.C. Files a Class Action Suit Against Northfield Laboratories, Inc. -- NFLD
PHILADELPHIA, March 20, 2006 (PRIMEZONE) -- Law Offices Bernard M. Gross, P.C. (http://www.bernardmgross.com) announces that a class action lawsuit, numbered 06-1493 was commenced in the United States District Court for the Northern District of Illinois, before the Honorable George M. Marovich, on behalf of purchasers of NORTHFIELD LABORATORIES, INC. ("NORTHFIELD" or the "Company") (Nasdaq:NFLD) securities during the class period between February 20, 2004 and February 21, 2006 , including purchasers in the May 2004 and February 2005 stock offerings, who have been damaged thereby.
Redefining Franchise Development; The Findley Group Creates New Approach for Taking Franchise From Conception to Established Name in the Marketplace
DALLAS, March 20, 2006 (PRIMEZONE) -- With its unique vision of the way franchise development ought to be done, the Findley Group is rapidly becoming the nation's premier franchise development firm -- in its very first year of operation. Founder Gary Findley has established the Findley Group upon his original franchising model that rocketed Curves International to the #1 fastest growing franchise in the world. Whereas other companies all but abandon franchisors after the initial buy-in, the Findley Group instead forms an ongoing relationship with each of its franchisors to ensure the final success of every concept developed underneath the umbrella of the Findley Group.
Photo Release -- David J. Fike, Ph.D., Named 8th President of Marygrove College
DETROIT, March 20, 2006 (PRIMEZONE) -- The Board of Trustees of Marygrove College announces the appointment of David J. Fike, Ph.D., as its new president, effective July 1, 2006. Dr. Fike is the current provost of Marygrove, having joined the College on August 1, 2005. He succeeds retiring Dr. Glenda D. Price, who has led Marygrove for eight years.
Vision Solutions Chief Scientist Dave Brown to Speak at COMMON Spring 2006
IRVINE, Calif., March 20, 2006 (PRIMEZONE) -- Vision Solutions, a leading high availability solution provider to the Global 5000, has announced that Dave Brown, chief scientist, will present "High Availability and System i5 Server Virtualization Trends" at the upcoming COMMON Spring 2006 IT Education Conference & Expo that is being held in Minneapolis, March 26-30. Brown's session will be on March 30th at 11 AM.
San Diego Gas & Electric
SDG&E Announces Route Options for the Sunrise Powerlink
SAN DIEGO, March 20, 2006 (PRIMEZONE) -- After months of analyzing data and gathering public input, San Diego Gas & Electric (SDG&E) today announced details of its proposed route for the Sunrise Powerlink, a new electric-transmission line from Imperial Valley, Calif., to the northwest portion of the utility's service territory in San Diego County. The line will deliver 1,000 megawatts to the region by 2010 -- enough energy for about 650,000 homes.
Medicis Pharmaceutical Corporation
Medicis to Ring the Opening Bell of the NYSE
SCOTTSDALE, Ariz., March 20, 2006 (PRIMEZONE) -- Medicis (NYSE:MRX) today announced the Company will be celebrating its recently announced agreement to license from Ipsen the aesthetic rights to Ipsen's botulinum toxin product, Reloxin(R), by ringing The Opening Bell(SM) of the New York Stock Exchange on Wednesday, March 22, 2006, at 9:30 a.m. ET. Ipsen will attend as a guest.
Medicis Pharmaceutical Corporation
Reloxin Agreement Between Ipsen and Medicis Becomes Effective
PARIS and SCOTTSDALE, Ariz., March 20, 2006 (PRIMEZONE) -- Ipsen (Eurolist by Euronext(TM): IPN FP) and Medicis (NYSE:MRX) today announced that the agreement whereby Ipsen Ltd, a wholly-owned subsidiary of Ipsen ("Ipsen"), grants Aesthetica Ltd, a wholly-owned subsidiary of Medicis ("Medicis"), rights to develop, distribute and commercialize Ipsen's botulinum toxin product in the United States, Canada and Japan for aesthetic use by physicians is now effective. The product is commonly referred to as Reloxin(R) in the U.S. aesthetic market and Dysport(R) for medical and aesthetic markets outside the U.S. The product is not currently approved for use in the U.S. Ipsen has recovered its rights to Reloxin(R) at the time of this announcement.
H&Q Asia Pacific
H&Q Asia Pacific Successfully Divests GoRemote Internet Communications, Inc. in Sale to iPass Inc.
PALO ALTO, Calif., March 20, 2006 (PRIMEZONE) -- H&Q Asia Pacific ("H&QAP") today announced that it has successfully divested its holdings in GoRemote Internet Communications, Inc. ("GRIC"), a leading provider of secure, managed broadband network services to large and mid-size distributed enterprises and services providers worldwide. H&QAP's divestment in GRIC was completed as a result of iPass Inc.'s (Nasdaq:IPAS) acquisition of GRIC, which closed in February 2006.